Association between tumor response to systemic therapy and patient-reported disease symptoms.

Ito, Yu; Awano, Nobuyasu; Takahashi, Naoko; Izumo, Takehiro; Kunitoh, Hideo

Ito, Yu; Awano, Nobuyasu; Takahashi, Naoko; Izumo, Takehiro; Kunitoh, Hideo.

Afiliação

Ito Y; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
Awano N; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
Takahashi N; Department of Palliative Care, Japanese Red Cross Medical Center, Tokyo, Japan.
Izumo T; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
Kunitoh H; Department of Medical Oncology, Japanese Red Cross Medical Center, Tokyo, Japan.

Jpn J Clin Oncol ; 52(12): 1423-1429, 2022 Dec 05.

Article em En | MEDLINE | ID: mdl-36062454

Assuntos

Neoplasias Pulmonares; Neoplasias; Humanos; Neoplasias/tratamento farmacológico; Neoplasias Pulmonares/terapia; Cuidados Paliativos; Imunoterapia; Medidas de Resultados Relatados pelo Paciente; Qualidade de Vida

Palavras-chave

Edmonton Symptom Assessment SystemRevised; lung cancer; objective response; patient-reported outcome; quality of life

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google